Specialization
Surgery
Focus of research
Pathological parameters and clinical outcomes of pancreatic cancer surgery
-
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy
Stoop, T. F., Oba, A., Wu, Y. H. A., Beaty, L. E., Colborn, K. L., Janssen, B. V., Al-Musawi, M. H., Franco, S. R., Sugawara, T., Franklin, O., Jain, A., Saiura, A., Sauvanet, A., Coppola, A., Javed, A. A., Groot Koerkamp, B., Miller, B. N., Mack, C. E., Hashimoto, D., Caputo, D., & 46 others, 18 Jun 2024, In: JAMA network open. 7, 6, p. e2417625Research output: Contribution to journal › Article › Academic › peer-review
-
Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials
Dutch Pancreatic Cancer Group, Oct 2023, In: The British journal of surgery. 110, 10, p. 1374-1380 7 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Correction to: Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer (Annals of Surgical Oncology, (2022), 29, 9, (5988-5999), 10.1245/s10434-022-11664-4)
the Dutch Pancreatic Cancer Group, Nov 2022, In: Annals of surgical oncology. 29, 12, p. 7820-7821 2 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications